Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
Regulatory Scrutiny: The proposed $35 billion merger between Capital One and Discover faces intense regulatory scrutiny from the New York Attorney General and federal regulators due to potential...
Resurgence in Dealmaking: Barclays witnessed a remarkable 58% surge in dealmaking fees, driven by a rebound in mergers and acquisitions (M&A) and debt capital markets (DCM) activity. Global M&A...
Regulatory Oversight Expansion: The Bank of England is enhancing its monitoring of the non-bank financial sector, including private equity firms, hedge funds, and asset managers, to address growing...
Surging Dealmaking Fees: Deutsche Bank reported a 24% year-over-year surge in dealmaking fees in Q2 2024, driven by robust debt underwriting and M&A advisory activity. Debt Underwriting Boom:...
Regulatory Scrutiny: The UK's Competition and Markets Authority (CMA) has launched a formal probe into Carlsberg's proposed £3.3 billion ($4.3 billion) takeover of Britvic, signaling heightened...
Robust Financials: Indian corporates boast strong balance sheets with healthy cash reserves and low debt levels, enabling them to pursue large-scale outbound M&A deals. Global Expansion: Driven by...
Dominance: Goldman Sachs and Houlihan Lokey emerged as leaders in M&A advisory for Q1-Q3 2024, with Goldman advising on $308.8B worth of deals and Houlihan leading in volume with 198 transactions....
Strategic Rationale: Domestic M&A presents an attractive option for Deutsche Bank to expand market share, achieve operational synergies, and diversify its business portfolio when conditions are...
Activist Investor Scrutiny: Starboard Value, a prominent activist investor, is calling for greater accountability from Pfizer's leadership over perceived overpaid M&A deals and poor returns on R&D...
Strategic Acquisitions: Mubadala Capital is actively pursuing large private equity stakes, aligning with its long-term investment philosophy focused on capital preservation and downside protection....
